These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H, Pu J, Zhou XL, Ning YY, Bai C. Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [Abstract] [Full Text] [Related]
5. SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways. Zhou J, Luo J, Gan R, Zhi L, Zhou H, Lv M, Huang Y, Liang G. Recent Pat Anticancer Drug Discov; 2024 May; 19(4):543-555. PubMed ID: 38305308 [Abstract] [Full Text] [Related]
7. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling. Wang HJ, Yang ZX, Dai XT, Chen YF, Yang HP, Zhou XD. Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094 [Abstract] [Full Text] [Related]
10. Antiproliferative Activity of Carnosic Acid is Mediated via Inhibition of Cell Migration and Invasion, and Suppression of Phosphatidylinositol 3-Kinases (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Signaling Pathway. Zhao L, Zhang J, Fan Y, Li Y. Med Sci Monit; 2019 Oct 21; 25():7864-7871. PubMed ID: 31631173 [Abstract] [Full Text] [Related]
11. Activation of endoplasmic reticulum stress promotes autophagy and apoptosis and reverses chemoresistance of human small cell lung cancer cells by inhibiting the PI3K/AKT/mTOR signaling pathway. Yu XS, Du J, Fan YJ, Liu FJ, Cao LL, Liang N, Xu DG, Zhang JD. Oncotarget; 2016 Nov 22; 7(47):76827-76839. PubMed ID: 27765907 [Abstract] [Full Text] [Related]
12. SNHG7 mediates cisplatin-resistance in non-small cell lung cancer by activating PI3K/AKT pathway. Chen K, Abuduwufuer A, Zhang H, Luo L, Suotesiyali M, Zou Y. Eur Rev Med Pharmacol Sci; 2019 Aug 22; 23(16):6935-6943. PubMed ID: 31486493 [Abstract] [Full Text] [Related]
13. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways. Jiang M, Zhou LY, Xu N, An Q. Thorac Cancer; 2019 Jun 22; 10(6):1319-1333. PubMed ID: 31055884 [Abstract] [Full Text] [Related]
15. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer. Yin C, Lin X, Wang Y, Liu X, Xiao Y, Liu J, Snijders AM, Wei G, Mao JH, Zhang P. Cell Oncol (Dordr); 2020 Jun 22; 43(3):395-407. PubMed ID: 32006253 [Abstract] [Full Text] [Related]
20. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells. Xiong F, Jiang M, Huang Z, Chen M, Chen K, Zhou J, Yin L, Tang Y, Wang M, Ye L, Zhan Z, Duan J, Fu H, Zhang X. Integr Cancer Ther; 2014 Mar 22; 13(2):152-60. PubMed ID: 24105357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]